U.S. and Europe CRO Partners Jump to: Agility Clinical  |  Cardiovacsular Clinical Science Foundation  |  CPC Clinical Research  |  CROS nt  |  ICON  |  iLS Clinical Research  |  Medtrials, Inc.  |  New England Research Institute Oculos Clinical Research  | Pegus Research  |  SynteractHCR  |  The Clinical Trial Company Agility Clinical is a unique consulting and contract research organization dedicated to working with virtual, small biopharma and device companies with a lean infrastructure.  We put our expertise and passion to work helping small companies – particularly those involved with orphan drug development – to move forward and bring important new treatments to patients. Learn More Cardiovascular Clinical Science Foundation Cardiovascular Clinical Science Foundation’s thought leadership and agile operations group deliver sponsor-focused research solutions for a single purpose: developing life-saving interventions for cardiovascular disease. From pre-marketing to post-marketing and everything in between, CCSF specializes in research services for the development of cardiovascular devices & diagnostics. Learn More CPC offers full service clinical trial design, oversight, and management with rapid access to Key Opinion Leaders in a variety of therapeutic areas. These individuals are on the cutting edge of scientific, clinical and regulatory developments. Many of CPC’s leadership team have chaired and/or served on FDA advisory committees including the Cardiovascular and Renal, Endocrine and Metabolism, and Reproductive Health committees. Learn More With a strong heritage in clinical data management and statistics, we offer a center of excellence for clinical trial data with a full service capability. Services include clinical data management, biostatistics programming and analysis, pharmaco- /device-vigilance, regulatory consultancy, monitoring, and medical writing – all underpinned by strong project management. These services are supported by industry-leading and proprietary technologies including data visualization, clinical analytics, EDC, eCOA, IVR, mHealth, data anonymization and data integrity analytics. Learn More ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs. Learn More iLS Research iLS Clinical Research has more than 17 years of experience in Clinical Research combining CRO and Pharmaceutical industries to deliver solutions adapted to the Latin American Market. Starting operations in Mexico and Central America, iLS plans to further expand its services to South American countries like Colombia, Argentina, Brazil and Peru. One of the main objectives for iLS Clinical Research is to integrate our experience to deliver solutions adapted to the Latin American market, contributing in parallel to the development of the industry in the region highlighting the multiple well known advantages of conducting clinical trials in Latin America and providing different and new treatment alternatives sooner. Learn More An established leader in the field of clinical research, MedTrials offers a full spectrum of professional services including clinical trial management, monitoring, data management, biostatistical analysis and reporting in all phases and types of clinical trials. MedTrials compliance experts conduct GxP audits at investigational sites, sponsors, manufacturers, IRBs and other third party vendors. MedTrials trainers are well known for delivering dynamic and innovative presentations and programs throughout the world. Learn More NERI is not your typical CRO. Our distinctive approach makes us sought after for over 30 years. We have remained true to our mission “No Research without Therapeutic or Policy Benefit” leveraging our scientific expertise to design, plan and execute global studies that derive the maximum information from every trial. Client confidence in early results allows rapid decision making and cost savings, while flexible and nimble strategic design can enable shorter trials with fewer participants for earlier approval. Our expertise in deriving the most from smaller studies has made NERI a leader in rare, orphan, and underserved diseases, as well as special populations such as pediatrics, the elderly, and minorities. Our commitment to science drives our research, and our understanding of commercial value drives our management processes. Learn More Oculos Clinical Research is a contract research organization (CRO) based in Tampa, Florida. OCR is focused in the area of ophthalmology and has the capability to manage all phases of human clinical trials. The Oculos team is focused on conducting the highest quality clinical research, but is also mindful of the need to conserve our clients’ critical financial resources. Oculos makes use of cutting edge technology and strategic partnerships to reduce costs for our customers. Oculos also maintains a network of quality ophthalmic clinical trial sites allowing us to scale up quickly and recruit effectively. Learn More Pegus Research PEGUS Research is a full-service health science and health service research organization with extensive experience in conducting health services research. PEGUS Research, Inc., offers a distinctive set of services to the pharmaceutical industry. We have 15 years of experience doing various kinds of observational studies, an area of research that is crucial to evaluating use and safety under real-world conditions. They include key opinion leader interviews, drug characterization studies, comprehensive label development research, and well-designed actual use trials for OTC switches or direct-to-OTC applications. Learn More We are dedicated to bringing new treatments to market, working closely with our clients in a spirit of “Shared Work – Shared Vision.” Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the continuum of Phase I – IV clinical studies with support services that address their specific needs. We offer notable experience in oncology, CNS, ophthalmology, pediatrics, rare and orphan diseases, and immunotherapy, among other indications. In collaboration with drug and device developers of all sizes we can bring tomorrow’s treatments to patients who need them, today. Learn More The Clinical Trial Research Group Our company’s professional approach provides cutting edge solutions in order to move clinical trials forward and provide exceptional services to our clients. Our philosophy is one of teamwork, positivity, communication, responsibility and adding value. We conduct clinical trials of all sizes in all therapeutic areas with a particular expertise in advanced therapies, such as cell and gene therapies, as well as Orphan drugs, CNS and medical devices. TCTC successfully executed clinical trials for the first Gene therapy to be approved in Europe. This approval trailblazes the way for other gene therapies in development and strengthens TCTC’s reputation as a leader in the field of Advanced Therapy Clinical Trials. Learn More Jump to: Agility Clinical  |  Cardiovacsular Clinical Science Foundation  |  CPC Clinical Research  |  CROS nt  |  ICON  |  iLS Clinical Research  |  Medtrials, Inc.  |  New England Research Institute Oculos Clinical Research  | Pegus Research  |  SynteractHCR  |  The Clinical Trial Company

U.S. and Europe CRO Partners

Breaker
Breaker
agility

Agility Clinical is a unique consulting and contract research organization dedicated to working with virtual, small biopharma and device companies with a lean infrastructure.  We put our expertise and passion to work helping small companies – particularly those involved with orphan drug development – to move forward and bring important new treatments to patients.

Breaker
CCS

Cardiovascular Clinical Science Foundation

Cardiovascular Clinical Science Foundation’s thought leadership and agile operations group deliver sponsor-focused research solutions for a single purpose: developing life-saving interventions for cardiovascular disease. From pre-marketing to post-marketing and everything in between, CCSF specializes in research services for the development of cardiovascular devices & diagnostics.

Breaker
CPC

CPC offers full service clinical trial design, oversight, and management with rapid access to Key Opinion Leaders in a variety of therapeutic areas. These individuals are on the cutting edge of scientific, clinical and regulatory developments. Many of CPC’s leadership team have chaired and/or served on FDA advisory committees including the Cardiovascular and Renal, Endocrine and Metabolism, and Reproductive Health committees.

Breaker
crosnt

With a strong heritage in clinical data management and statistics, we offer a center of excellence for clinical trial data with a full service capability. Services include clinical data management, biostatistics programming and analysis, pharmaco- /device-vigilance, regulatory consultancy, monitoring, and medical writing – all underpinned by strong project management. These services are supported by industry-leading and proprietary technologies including data visualization, clinical analytics, EDC, eCOA, IVR, mHealth, data anonymization and data integrity analytics.

Breaker
icon_logo

ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.

Breaker
ils

iLS Research

iLS Clinical Research has more than 17 years of experience in Clinical Research combining CRO and Pharmaceutical industries to deliver solutions adapted to the Latin American Market. Starting operations in Mexico and Central America, iLS plans to further expand its services to South American countries like Colombia, Argentina, Brazil and Peru.

One of the main objectives for iLS Clinical Research is to integrate our experience to deliver solutions adapted to the Latin American market, contributing in parallel to the development of the industry in the region highlighting the multiple well known advantages of conducting clinical trials in Latin America and providing different and new treatment alternatives sooner.

Breaker
Med

An established leader in the field of clinical research, MedTrials offers a full spectrum of professional services including clinical trial management, monitoring, data management, biostatistical analysis and reporting in all phases and types of clinical trials. MedTrials compliance experts conduct GxP audits at investigational sites, sponsors, manufacturers, IRBs and other third party vendors. MedTrials trainers are well known for delivering dynamic and innovative presentations and programs throughout the world.

Breaker
neri

NERI is not your typical CRO. Our distinctive approach makes us sought after for over 30 years. We have remained true to our mission “No Research without Therapeutic or Policy Benefit” leveraging our scientific expertise to design, plan and execute global studies that derive the maximum information from every trial. Client confidence in early results allows rapid decision making and cost savings, while flexible and nimble strategic design can enable shorter trials with fewer participants for earlier approval. Our expertise in deriving the most from smaller studies has made NERI a leader in rare, orphan, and underserved diseases, as well as special populations such as pediatrics, the elderly, and minorities. Our commitment to science drives our research, and our understanding of commercial value drives our management processes.

Breaker
Oculogo

Oculos Clinical Research is a contract research organization (CRO) based in Tampa, Florida. OCR is focused in the area of ophthalmology and has the capability to manage all phases of human clinical trials. The Oculos team is focused on conducting the highest quality clinical research, but is also mindful of the need to conserve our clients’ critical financial resources. Oculos makes use of cutting edge technology and strategic partnerships to reduce costs for our customers. Oculos also maintains a network of quality ophthalmic clinical trial sites allowing us to scale up quickly and recruit effectively.

Breaker
pegus

Pegus Research

PEGUS Research is a full-service health science and health service research organization with extensive experience in conducting health services research. PEGUS Research, Inc., offers a distinctive set of services to the pharmaceutical industry. We have 15 years of experience doing various kinds of observational studies, an area of research that is crucial to evaluating use and safety under real-world conditions. They include key opinion leader interviews, drug characterization studies, comprehensive label development research, and well-designed actual use trials for OTC switches or direct-to-OTC applications.

Breaker
synteract

We are dedicated to bringing new treatments to market, working closely with our clients in a spirit of “Shared Work – Shared Vision.” Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the continuum of Phase I – IV clinical studies with support services that address their specific needs. We offer notable experience in oncology, CNS, ophthalmology, pediatrics, rare and orphan diseases, and immunotherapy, among other indications. In collaboration with drug and device developers of all sizes we can bring tomorrow’s treatments to patients who need them, today.

Breaker
tctcg

The Clinical Trial Research Group

Our company’s professional approach provides cutting edge solutions in order to move clinical trials forward and provide exceptional services to our clients. Our philosophy is one of teamwork, positivity, communication, responsibility and adding value. We conduct clinical trials of all sizes in all therapeutic areas with a particular expertise in advanced therapies, such as cell and gene therapies, as well as Orphan drugs, CNS and medical devices. TCTC successfully executed clinical trials for the first Gene therapy to be approved in Europe. This approval trailblazes the way for other gene therapies in development and strengthens TCTC’s reputation as a leader in the field of Advanced Therapy Clinical Trials.